in view of evidence linking cholecystokinin-containing neurons with both dopamine system function and parkinson 's disease pathophysiology , the therapeutic effects of the cholecystokinin analog , caerulein , were evaluated in 10 parkinsonian patients stabilized on l-dopa therapy .
C0030567
parkinson 's disease
C0023570
l-dopa